175 related articles for article (PubMed ID: 7756153)
1. Topical mometasone furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivo.
Koivukangas V; Karvonen J; Risteli J; Oikarinen A
Br J Dermatol; 1995 Jan; 132(1):66-8. PubMed ID: 7756153
[TBL] [Abstract][Full Text] [Related]
2. Effect of hydrocortisone, methylprednisolone aceponate and momethasone furoate on collagen synthesis in human skin in vivo.
Haapasaari KM; Risteli J; Karvonen J; Oikarinen A
Skin Pharmacol; 1997; 10(5-6):261-4. PubMed ID: 9449164
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo.
Haapasaari KM; Risteli J; Koivukangas V; Oikarinen A
Acta Derm Venereol; 1995 Jul; 75(4):269-71. PubMed ID: 8578945
[TBL] [Abstract][Full Text] [Related]
4. Different skin thinning potential of equipotent medium-strength glucocorticoids.
Korting HC; Unholzer A; Schäfer-Korting M; Tausch I; Gassmueller J; Nietsch KH
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):85-91. PubMed ID: 11867964
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Bjerring P
Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
[TBL] [Abstract][Full Text] [Related]
6. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects.
Haapasaari KM; Risteli J; Oikarinen A
Br J Dermatol; 1996 Jul; 135(1):65-9. PubMed ID: 8776361
[TBL] [Abstract][Full Text] [Related]
7. Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro.
Wach F; Bosserhoff A; Kurzidym U; Nowok K; Landthaler M; Hein R
Skin Pharmacol Appl Skin Physiol; 1998; 11(1):43-51. PubMed ID: 9603668
[TBL] [Abstract][Full Text] [Related]
8. A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment.
Oikarinen A; Autio P; Kiistala U; Risteli L; Risteli J
J Invest Dermatol; 1992 Feb; 98(2):220-5. PubMed ID: 1732386
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical tretinoin on non-sun-exposed human skin connective tissue: induction of tenascin but no major effect on collagen metabolism.
Haapasaari KM; Kallioinen M; Tasanen K; Sutinen M; Annala AP; Risteli J; Oikarinen A
Br J Dermatol; 1997 Jun; 136(6):891-900. PubMed ID: 9217822
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of transforming growth factor-beta by betamethasone-17- valerate and isotretinoin: corticosteroid decreases and isotretinoin increases the level of transforming growth factor-beta in suction blister fluid.
Leivo T; Arjomaa P; Oivula J; Vesterinen M; Kiistala U; Autio P; Oikarinen A
Skin Pharmacol Appl Skin Physiol; 2000; 13(3-4):150-6. PubMed ID: 10859533
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of glucocorticoid-induced skin atrophy: topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo.
Oikarinen A; Haapasaari KM; Sutinen M; Tasanen K
Br J Dermatol; 1998 Dec; 139(6):1106-10. PubMed ID: 9990383
[TBL] [Abstract][Full Text] [Related]
12. A thyroid hormone analogue, triiodothyroacetic acid, corrects corticosteroid-downregulated collagen synthesis.
Yazdanparast P; Carlsson B; Oikarinen A; Risteli J; Faergemann J
Thyroid; 2004 May; 14(5):345-53. PubMed ID: 15186610
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial.
Reitamo S; Rissanen J; Remitz A; Granlund H; Erkko P; Elg P; Autio P; Lauerma AI
J Invest Dermatol; 1998 Sep; 111(3):396-8. PubMed ID: 9740230
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
Kerscher MJ; Hart H; Korting HC; Stalleicken D
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
[TBL] [Abstract][Full Text] [Related]
15. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Szadurski J; Renz F; Gasser D
Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
[TBL] [Abstract][Full Text] [Related]
16. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses.
Viglioglia P; Jones ML; Peets EA
J Int Med Res; 1990; 18(6):460-7. PubMed ID: 2292327
[TBL] [Abstract][Full Text] [Related]
17. Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue.
Isogai M; Shimizu H; Esumi Y; Terasawa T; Okada T; Sugeno K
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):141-5. PubMed ID: 8439518
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients.
Haapasaari K; Rossi O; Risteli J; Oikarinen A
Eur Respir J; 1998 Jan; 11(1):139-43. PubMed ID: 9543283
[TBL] [Abstract][Full Text] [Related]
19. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
Prakash A; Benfield P
Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
[TBL] [Abstract][Full Text] [Related]
20. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
Kerscher MJ; Korting HC
Acta Derm Venereol; 1992; 72(3):214-6. PubMed ID: 1357864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
